Advertisement
Home Tags Cancer: Mouth

Tag: Cancer: Mouth

Epigenetic Age Acceleration Up in Head and Neck Cancer

0

Correlation found for increased EAA with elevated fatigue, which was mediated by inflammatory markers CRP, IL-6

Aumenta el cáncer de esófago entre los jóvenes

Timing, Intensity of Oral Sex Are Risk Factors for HPV-OPC

0

Increased odds of human papillomavirus oropharyngeal cancer seen for younger age at first oral sex, oral sex intensity

Head and Neck Cancer Surgery Seems Safe During COVID-19

0

Links seen for severe pulmonary complications in COVID-19-positive patients with advanced tumor stage, critical care admission

For patients with early-stage oropharyngeal cancer

Transoral Robotic Surgery Ups Survival in Oropharyngeal Cancer

0
Outcomes and survival improved for early-stage oropharyngeal cancer, but not other cancers
From 2007 to 2016

CDC: 2009 to 2017 Saw Increase in Oral Cavity, Pharynx Cancers

0
Incidence dropped for cancers of lip, floor of mouth, soft palate and uvula, hard palate, hypopharynx, nasopharynx
Nonwhite

Race, Insurance Status Linked to Lower Cancer Survival

0
Reduced survival seen in HPV-associated head and neck cancer for nonwhite, uninsured patients
For patients with oropharynx cancer

Mortality Risk in Oropharynx Cancer Varies Based on HPV Status

0
Patients with OPC with HPV-negative tumors have increased risk for head and neck cancer mortality
The checkpoint inhibitor pembrolizumab prolongs survival in patients with certain head and neck cancers

Pembrolizumab Prolongs Survival in Advanced Head, Neck Cancer

0
Authors recommend pembrolizumab, with or without chemotherapy, as first-line treatment
Nonsteroidal anti-inflammatory drugs are correlated with better overall survival in patients with head and neck squamous cell carcinoma

ASTRO: NSAIDs May Offer Benefit to Head & Neck Cancer Patients

0
Benefit not significant for aspirin use in patients with non-small cell lung cancer undergoing SBRT
Delaying time to treatment initiation beyond 60 days is associated with decreased overall survival and increased head and neck cancer recurrence

Delaying Treatment Worsens Head, Neck Cancer Outcomes

0
Findings show that survival declines, recurrence increases with delays of more than 60 days